Funds holding Shenzhen Hepalink Pharmaceutical Group Co Ltd
ISIN CNE100000P02 · China
- Fund holders
- 12
- Of which ETFs
- 6 6 other funds
- Value held
- 3.2M $ 1.2M SEK
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS | 727,807 | 1.2M $ | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD EMERGING MARKETS STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 706,401 | 1.1M $ | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio Emerging Markets ETF SPDR INDEX SHARES FUNDS | 340,700 | 559.4K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD FTSE ALL-WORLD EX-US INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 112,000 | 178.5K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Handelsbanken Emerging Markets Index Handelsbanken Fonder AB | 75,400 | 1.2M SEK | 0.01 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) China ETF SPDR INDEX SHARES FUNDS | 60,724 | 99.7K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 30,000 | 47.8K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Strategic Advisers International Fund Fidelity Rutland Square Trust II | 17,700 | 31K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD ESG INTERNATIONAL STOCK ETF VANGUARD WORLD FUND | 8,200 | 14.4K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF DBX ETF Trust | 1,751 | 3.1K $ | 0.00 % | as of Feb 27, 2026 ↗ |
| Goldman Sachs MarketBeta Total International Equity ETF Goldman Sachs ETF Trust II | 794 | 1.4K $ | 0.00 % | as of Feb 27, 2026 ↗ |
| Goldman Sachs MarketBeta Emerging Markets Equity ETF Goldman Sachs ETF Trust | 463 | 811.2 $ | 0.00 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| State Street(R) SPDR(R) S&P(R) China ETF SPDR INDEX SHARES FUNDS | 0.02 % | as of Mar 31, 2026 ↗ |
| Handelsbanken Emerging Markets Index Handelsbanken Fonder AB | 0.01 % | as of Mar 31, 2026 ↗ |
| Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF DBX ETF Trust | 0.00 % | as of Feb 27, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio Emerging Markets ETF SPDR INDEX SHARES FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD EMERGING MARKETS STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 0.00 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs MarketBeta Emerging Markets Equity ETF Goldman Sachs ETF Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs MarketBeta Total International Equity ETF Goldman Sachs ETF Trust II | 0.00 % | as of Feb 27, 2026 ↗ |
| VANGUARD ESG INTERNATIONAL STOCK ETF VANGUARD WORLD FUND | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD FTSE ALL-WORLD EX-US INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS | 0.00 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 11 | -1 | 2,006,540 | +0.8 % |
| 2026Q1 | 12 | 0 | 1,990,284 | +5.3 % |
| 2025Q4 | 12 | +2 | 1,890,584 | +7.9 % |
| 2025Q3 | 10 | -1 | 1,752,860 | -0.1 % |
| 2025Q2 | 11 | 0 | 1,753,782 | +0.7 % |
| 2025Q1 | 11 | +1 | 1,742,182 | +0.7 % |
| 2024Q4 | 10 | -1 | 1,729,895 | -8.0 % |
| 2024Q3 | 11 | 0 | 1,880,431 | -20.9 % |
| 2024Q2 | 11 | +1 | 2,378,695 | +177.8 % |
| 2024Q1 | 10 | -6 | 856,202 | -84.1 % |
| 2023Q4 | 16 | 5,400,810 |
Cite this page
Titelia. "Funds holding Shenzhen Hepalink Pharmaceutical Group Co Ltd". https://titelia.com/en/stocks/shenzhen-hepalink-pharmaceutical-group-co-ltd-CNE100000P02